Updated October 22, 2021
We recognize the challenges COVID-19 and associated state and federal mandates regarding business operations pose to you, your employees, and your business. Our top priority is supporting employees’ access to vaccines, connecting them to care and supporting you, our valued business partners, during this evolving crisis.
The following information is a compilation of the most frequent questions we have received to date. We have attempted to provide responses that apply in the broadest sense. As always, your account executive is available to answer questions specific to your plan.
The health of our members is our top priority. Read the latest actions we’re taking to support our members.
No pre-authorization or cost shares for COVID-19 vaccinations, testing and treatment through 12/31/21
No-cost COVID-19 vaccinations. The federal government is paying for enough vaccine doses to immunize every American during the course of the pandemic. Administrative fees will be covered by most health plans. Legacy and retiree only plans are not required to cover administration without cost-sharing.
No-cost shares or pre-authorization requirement for COVID-19 treatment by in-network providers through 12/31/21.
No-cost diagnostic (antigen and molecular) testing, including provider visit. This includes high-deductible health plans with HSAs. Tests must be performed at a CLIA-certified lab, or the test manufacturer must have FDA Emergency Use Authorization.
No-cost COVID-19 antibody testing when ordered by a member’s attending physician and part of appropriate medical care. Tests must be performed at a CLIA-certified lab, or the test manufacturer must have FDA Emergency Use Authorization.
As with drug testing for employment, health insurance does not cover COVID-19 testing for employment, surveillance, or extracurricular activities, such as travel, school, sports or summer camps.
- Extending any expiring prior authorizations for elective services when requested, by up to three months, or through 12/31/21, whichever is latest
Enhanced support for high-risk members
We’re in contact with high-risk members using our case management services to ensure they have the support they need.
As we learn of members hospitalized with the virus, we are reaching out to provide personalized support.
- We’re moving members on infused medications from hospital to home settings or infusion centers.
Access to needed medications
Members may receive early refills of most medications through the end of the declaration of emergency in the state where their plan is issued, so they have enough on hand.
Members can request a 90-day refill of medications for chronic conditions such as heart disease, asthma, diabetes and others. Some drugs are not eligible for extended day supply, including controlled substances and certain specialty drugs (ineligible drugs are those in the “Narcotics” section or marked “SP” on our drug lists).
- Members with prescription coverage through Regence can order home-delivery prescriptions through the AllianceRx Walgreens Prime website.
Enhancing coverage for virtual care
To help slow the spread of infection and ease pressure on providers’ offices and emergency rooms, we’ve enhanced coverage for virtual care:
Members have access to telehealth vendors that provide services such as video visits and secure messaging with doctors and nurses, and home health visits in select areas. These options may differ by employer, and employers can consult their summary of benefits coverage (SBC) for their specific telehealth offering. Employees should sign-in or create an account on regence.com, or download the Regence app, to learn about the virtual care options included in their plan. A flyer and video on regence.com contain all the instructions for doing this; be sure all employees have access to these instructions.
We’ve expanded the services that can be delivered by providers using virtual care options.
- Members’ own providers, including PCPs, behavioral health specialists, and others, may also have virtual care options. If members don’t have a doctor or therapist, they should call Customer Service for help finding one.
Expanding resources for self-care
To help members address a wide range of emotional and physical health needs, we’ve broadened access to three useful tools:
Active&Fit – members have free access to 200 on-demand digital workout videos and daily live workouts from Active&Fit. Enrollment in Active&Fit is not required; Regence members need only to access the Active&Fit website from their Regence account page and register there to receive access to the workout videos.
Regence Empower™ – provides members tips for staying healthy, what to do when sick, and advice to help slow the spread of the disease. Includes self-guided programs for managing stress, enhancing physical activity, and building resilience, along with personal challenges supporting sleep, nutrition, physical activity, and social and emotional well-being.
- Symptom Checker – offers members timely guidance and support to help them determine whether medical attention is needed. Not intended to replace a clinical assessment or the judgment of health care professionals.
Groups may use the standard leave of absence guidelines up to three months for employees for any acceptable reason by the group, including for a reduction of hours. Leave of absence is at the employer's discretion and is managed by the employer.
At the end of three months, employees need to return to an active, at-work status, or terminate from the plan. Options for coverage may include state continuation of coverage, FMLA, COBRA or state exchanges.
We will look to the client to monitor eligibility that is passed to our systems. Temporarily employees can maintain their coverage on their Regence plans as long as the reduction in hours/layoff is a temporary measure resulting from COVID-19, the group continues to pay premiums and the employees are not terminated.
Yes, if the employee is recalled within three months of termination and had previously satisfied the waiting period.
Yes. They can return to the plan within three months. If the employee maintains their Regence member ID #, their out-of-pocket accumulators will be carried forward.
Employers up to 100 employees may temporarily self-administer hours of eligibility to the contract minimums without prior approval. Minimums are established by states as follows:
- Idaho – 20 hours
- Oregon – 17.5 hours (no state minimum, market standard)
- Utah – 30 hours
- Washington – 20 hours (no state minimum, market standard)
Yes, to 50 percent of the lowest-cost health plan offered to your employees. The employee contribution would increase to cover the full premium.
Yes, as long as there is active enrollment on the plan. If all employees are terminated from a plan, the contract will be cancelled and you would need to reapply for coverage.
We are not offering special COVID-19 enrollment at this time. Some state-based exchanges are offering a special enrollment period for individual participants.
Yes. Groups with fewer than 50 employees would need to establish a new 12-month contract by completing a renewal GMA. During that process, they can select lower benefits, a different contribution amount, and different eligibility guidelines. Groups 51+ should contact their account executive to determine the options that best fit their needs. For groups with 50 or fewer employees, a renewal GMA is required.
Small employers may with underwriting approval change benefits off anniversary. This requires a new contract, including rates and current mandated benefits. If employers make a mid-year contract change, employees may then select a new plan and enroll (if eligible) or disenroll in coverage.
Mid-size (51-100) employers may with underwriting approval make a mid-year benefit buy down. Underwriting and sales will map enrollment from one plan to the other and no additional enrollment changes will be allowed. Employees may not voluntarily change plan elections outside of a contract re-write or their scheduled open enrollment.
Premium grace periods are state specific and comply with emergency orders:
- Idaho – 30 days
- Oregon – 60 days
- Utah – 30 days
- Washington – 30 days
We are covering COVID-19 vaccinations, antigen and molecular diagnostic testing (and the associated office visit) during the state of emergency, and treatment at no cost share to the member into 2021. Testing must be ordered by a medical professional. We also cover COVID-19 antibody tests at no member cost share when ordered by a member’s attending physician and part of appropriate medical care. COVID-19 tests must be performed at a CLIA-certified lab, or the test manufacturer must have FDA Emergency Use Authorization. As with other tests for employment, such as drug tests, antibody tests for employment purposes are not covered by insurance.
Your health plan may include an Employee Assistance Plan (EAP) benefit. Telehealth vendors also provide behavioral health services. In addition, members’ regular providers may be able to offer telehealth services through our temporary expanded virtual care services.
Yes, you can add Doctor on Demand. Call your account executive to learn more.
To help prevent the spread of infection and ease pressure on doctor’s offices, urgent care centers and emergency rooms, we have temporarily expanded the services available through our telehealth benefit. Any contracted provider may now offer virtual care services, even on a non-HIPAA-compliant platform. This includes routine preventive appointments with members’ primary care doctors and behavioral health providers. This expansion remains in effect into 2021. The member’s coinsurance and deductible will apply to these services.
This rule applies to ERISA groups only. COBRA remains an employer-specific responsibility. The following represents our understanding at this point in time.
The DOL, IRS and HHS guidance under the EBSA Disaster Relief Notice 2020-01 extends certain COBRA timeframes and deadlines for participants to consider coverage elections and benefits decisions.
Specifically, Final Rule provides plan participants, beneficiaries, qualified beneficiaries, and claimants with relief from meeting the below referenced periods and dates during the period of March 1, 2020 until 60 days after the announced end of the COVID-19 National Emergency (or such other date announced by the Agencies in a future notice):
- The 30-day period (or 60-day period, if applicable) to request a special enrollment;
- The 60-day election period for COBRA continuation coverage;
- The date/deadline for making COBRA premium payments;
- The deadline for individuals to notify the plan of a qualifying event or determination of disability;
- The deadline within which employees can file a benefit claim, or a claimant can appeal an adverse benefit determination, under a group health plan’s or disability plan’s claims procedures;
All vaccines that have received approval or emergency use authorization from the U.S. Food and Drug Administration (FDA) for public distribution are covered. These include the Pfizer-BioNTech (now called Comirnaty), Moderna and Johnson & Johnson vaccines. The federal government is paying for enough vaccine for every American to be vaccinated during the course of the pandemic.
Vaccine administration is covered at no out-of-pocket cost for Medicare, fully insured and most ASO members. Legacy and retiree only plans are not required to cover administration without cost-sharing. However, we have chosen to cover the administrative fee for fully insured legacy plans without cost-sharing.
Balance billing is not permitted. From the Centers for Disease Control and Prevention (CDC): “Providers that participate in the CDC COVID-19 Vaccination Program contractually agree to administer a COVID-19 vaccine regardless of an individual’s ability to pay and regardless of their coverage status, and also may not seek any reimbursement, including through balance billing, from a vaccine recipient.”
COVID-19 vaccines are available to all members age 12 and older. Trials on the efficacy and safety of vaccines in children under age 12 are underway and the FDA is expected to issue emergency use authorization for their use in the future.
The FDA has approved the two-dose Pfizer-BioNTech vaccine (now called Comirnaty) for people age 16 and older, and Emergency Use Authorization (EUA) for people age 12-15. In addition, the FDA has approved EUA for the one-dose Janssen (Johnson & Johnson) and two-dose Moderna vaccines for people age 18 and older.
The CDC has authorized COVID-19 booster shots for the following high-risk populations:
- individuals 65 years of age and older;
- individuals 18 through 64 years of age at high risk of severe COVID-19; and
- individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.
COVID-19 booster shots are authorized for people in the high-risk populations listed above as follows:
- At least six months after receiving their primary two doses of the Comirnaty or Moderna vaccines
- At least two months after receiving their primary dose of the Janssen (Johnson & Johnson) vaccine
COVID-19 vaccines are widely available through healthcare providers and pharmacies everywhere in the U.S. Employers with Regence health plans can host an onsite vaccination clinic, providing COVID-19, influenza, tetanus, hepatitis and other routine vaccinations with no out-of-pocket costs to employees and covered dependents. Click on your state name below for more information about employer onsite vaccination clinics.
Each state’s health department will have specific information about vaccine prioritization and distribution.
We are working to encourage all members to work with their medical provider to get vaccinated. Regence is working with our community partners, public officials and others to ensure that underserved communities and people of color – groups that have been disproportionally affected by the pandemic – are vaccinated.
Members should check their state’s health department website or call their doctor or pharmacist to schedule an appointment to receive the vaccine.
The CDC provides these resources to learn more about the COVID-19 vaccine:
The vaccine itself doesn’t cost consumers anything regardless of insurance coverage. The federal government has bought enough vaccine doses to immunize every American. The Centers for Medicare and Medicaid Services (CMS) or private insurance pays for the administration of the vaccine. Older legacy plans may pass administration costs on to their members.
It is too early to tell if COVID-19 will have an impact on future premiums.
The administrative fee for the flu vaccine is around $7 versus the fee for administering the COVID-19 vaccine, which is currently around $45. In addition to the administrative fee, vaccine costs will vary based on manufacturer pricing. At present, all drug costs for COVID-19 vaccines are being covered by the government.
We follow the New York Times vaccine tracker for the latest on vaccines and suggest you do too.
Lead by example. Everyone can contribute to community health by:
- Getting vaccinated.
- Practicing the three Ws: wear a mask when in public, wash hands frequently, watch your distance from those outside your household.
- Quarantining at the first sign of possible infection symptoms or when exposed to someone who is known to be infected.
- Stopping the spread of misinformation. Check your information sources before sharing information about the pandemic with anyone. When in doubt, rely on your state health department, the FDA or the CDC.
There is evidence that vaccine efficacy begins to wane after several months, and medical experts are learning more about vaccine efficacy as more time passes since the first eligible recipients were vaccinated in late 2020 and early 2021. Top medical and public health experts and the U.S. Department of Health and Human Services recently issued guidance for all American adults that received the Moderna or Pfizer-BioNTech (Comirnaty) mRNA vaccine to receive a third dose eight months after their second dose, pending FDA approval; however, at this time, only a third booster dose of Comirnity has been approved by the FDA, and only for the following high-risk populations:
- Individuals 65 years of age and older
- Individuals 18 through 64 years of age at high risk of severe COVID-19; and
- Individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.
Research is still being done to determine whether boosters will be authorized for recipients of the one-shot Johnson & Johnson vaccine. People are still considered fully vaccinated after receiving their single dose of J&J or their second dose of the Moderna or Comirnaty vaccines.
The CDC will be your best source of information about vaccines for COVID-19.
Medical experts advise getting whichever vaccine is available to you. They all protect against serious illness and death.
The current vaccines do not contain the coronavirus or inactivated virus. NPR offers a great explanation on what vaccine efficacy means. Getting vaccinated can dramatically reduce the chance of you getting COVID-19. If you still get infected and have symptoms, the vaccine can protect you against serious illness. Currently with people who’ve been vaccinated and still contracted COVID-19, the death rate is zero and one person was hospitalized.
Vaccines are developed by teams of world-class scientists with many years of education and experience. All vaccines undergo extensive trials to prove safety and effectiveness, involving tens of thousands of people who volunteer to receive the vaccine. The FDA grants emergency use authorization (EUA) only when independent analyses confirm a vaccine is safe and effective. Full approval is granted when, over time, the FDA has amassed even more scientific evidence to support use of the COVID-19 vaccines, showing that the benefits of the vaccine are greater than its risks, and that the vaccines can be manufactured reliably, safely and with consistent quality.
The Pfizer-BioNTech (now called Comirnaty) and Moderna vaccines have an effectiveness rate of more than 95%. While these vaccines were developed in 2020, the technology behind them has been studied for years. The vaccines do not contain the virus or inactivated virus. You cannot get COVID-19 from the COVID-19 vaccines.
Comirnaty has received full FDA approval for people 16 years of age or older, and EUA for people 12 to 15 years of age and as a booster for high-risk populations. COVID-19 vaccines manufactured by Johnson & Johnson (also known as Janssen Biotech, a pharmaceutical company of J&J) and Moderna vaccines have received EUA for people 18 years of age or older.
We recommend reviewing the New York Times vaccine tracker for a plain language explanation of how vaccines are developed and what phase COVID-19 vaccines are currently in.
We recommend following CDC recommendations: "The safety and efficacy of a mixed-product series have not been evaluated. Both doses of the series should be completed with the same product."
The CDC has authorized the mixing of different COVID-19 vaccines for boosters for people in high-risk populations.
Yes. The current vaccines help protect against moderate to severe illness and death. The emergence and transmission of new virus strains is highly dynamic, and we suggest referring to the CDC for the most current information.
The majority of people will experience no side effects other than a sore arm. About 10% may have flu like symptoms for a couple of days as the body develops antibodies. This is normal and generally not cause for alarm. Providers typically require vaccine recipients to wait for a 15 to 30-minute observation period just to be safe.
The CDC says that serious side effects that could cause a long-term health problem are extremely unlikely following any vaccination, including COVID-19 vaccination. The CDC offers comprehensive information about vaccine safety and monitoring.
Yes. Fully vaccinated people can still contract the coronavirus that causes COVID-19, and spread it to other vaccinated and unvaccinated people. As with the unvaccinated, a vaccinated person can contract the coronavirus and experience a range of symptoms. In rare cases, a vaccinated person who contracts COVID-19 can experience moderate to severe symptoms requiring hospitalization.
Even after receiving a vaccination, safety protocols including masking, distancing, washing hands frequently, and quarantining if symptoms or exposure to a known infected person occur are all strongly recommended to help prevent the spread of COVID.
No. J & J is not a mRNA vaccine but a vector-based vaccine using a modified adenovirus using a double stranded DNA to cause the host cell to produce mRNA and spike proteins resulting in an immune response (antibodies) ready to attack a COVID-19 virus. For more information, read: How the Johnson & Johnson Covid-19 Vaccine Works - The New York Times (nytimes.com)
Yes. The Novavax is an example of such a vaccine technology. How the Novavax Covid-19 Vaccine Works - The New York Times (nytimes.com)
Clinical trials on the safety and efficacy of COVID-19 vaccines for children under 12 are underway, and it is anticipated that one or more will receive EUA in the future.
Some immunocompromised individuals should not get a COVID-19 vaccination. Please consult with your doctor if you have any questions about getting vaccinated, whether related to allergies, pregnancy, or other medical or health conditions.
Medical evidence shows that getting a COVID-19 vaccination can help keep you, your family, your community, and your country healthy and safe. Getting vaccinated can greatly reduce your chances of experiencing moderate to severe illness and death should you contract the coronavirus.
Available COVID-19 vaccines have undergone rigorous clinical trials to prove safety and effectiveness before they receive permission from the FDA for broad distribution. Clinical trials involve tens of thousands of people who volunteer to receive the vaccine. The FDA grants emergency use authorization only if independent analysis confirms the vaccines are safe and effective.
Regence health plans cover FDA-approved treatment for COVID-19. Ivermectin is not approved for the prevention or treatment of COVID-19. There is no clinical evidence supporting the efficacy of Ivermectin for treatment of COVID-19 symptoms.
Yes, the CDC has issued guidance recommending continued mask wearing, physical distancing and frequent handwashing when in public places. Many states have reinstituted public mask wearing mandates since the most recent COVID-19 surge, fueled by the Delta variant, began. In addition, quarantining immediately when symptoms or exposure to an infected person occur is also strongly recommended.
It takes a few weeks for your body to build up immunity after vaccination. In addition, while the vaccines have a high efficacy rate for preventing serious illness and death, a vaccinated person may still be susceptible to getting the virus and transmitting it to others.
Check with your state or local health department on additional safety protocols for your community.
That really depends on us. If we continue to mask up, maintain physical distance, wash hands frequently, and quarantine at the first occurrence of symptoms or exposure to a known infected person, we can help stop the virus from spreading. Your state and local health departments will be your best source of information about community safety protocol.
Medical experts do not know for sure. Herd immunity occurs when the vast majority of a population is immune from an infection. For highly infectious viruses such as measles, herd immunity occurs when 92 – 94% of the population is immune. At 70 – 80% herd immunity, we would start to see a reduction in case rates. The CDC will be your best source of information about herd immunity for COVID-19.
It is unknown how long natural immunity lasts. Reinfection with COVID-19 is common, and often with more severe symptoms than the initial infection. If it’s been more than 90 days since you’ve had COVID-19, medical experts recommend getting vaccinated.
Yes. Employers can begin scheduling onsite vaccination clinics. Many onsite vaccination clinic providers offer COVID-19 and flu shots. And, to help employees catch up on other routine annual vaccinations, many providers also offer shots for hepatitis, pneumonia, shingles, tetanus, and more. Employers should contact their Regence account representative for more information about how to schedule an onsite vaccination clinic.
The U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) is working on rulemaking to require that all employers with 100 or more employees ensure their workforce is fully vaccinated—or require unvaccinated workers to produce a negative COVID-19 test result on at least a weekly basis before coming to work. It’s estimated that some 80 million workers nationwide will be affected by this rule. We’ll provide additional details as regulations are released. You can learn more about the vaccine mandate at https://www.whitehouse.gov/covidplan/.
Please consult your legal counsel.
The recording of the full webinar is available for playback and future reference here. If you need ongoing updates related to COVID-19 and our efforts to support you at this time, please contact your account manager.
Centers for Disease Control and Prevention (CDC)
World Health Organization (WHO)
New York Times vaccine tracker
Oregon Health Authority
Washington Department of Health
Utah Department of Health
Idaho Department of Health